The wisdom of crowds and the repurposing of artesunate as an anticancer drug

ecancermedicalscience

Volumn 9, Issue SpecialIssue, 2015, Pages

  Augustin, Yolanda ^a   Krishna, Sanjeev ^a   Kumar, Devinder ^a   Pantziarka, Pan ^b,c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Anticancer Fund   (Belgium)

^c George Pantziarka TP53 Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARTESUNATE; CIMETIDINE; KETOROLAC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84995644704     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2015.ed50     Document Type: Article

References (15)

1. Tu Y (2011) The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine Nat Med 17(10) pp 1217-20 doi: 10.1038/nm.2471 PMID: 21989013
2. Woodrow CJ, Haynes RK and Krishna S (2005) Artemisinins Postgrad Med J 81(952) pp 71-8 DOI: 10.1136/pgmj.2004.028399 PMID: 15701735 PMCID: 1743191
3. Efferth T (2005) Mechanistic perspectives for 1, 2, 4-trioxanes in anti-cancer therapy Drug Resist Updat 8(1-2) pp 85-97 DOI: 10.1016/j.drup.2005.04.003 PMID: 15878303
4. Krishna S et al (2008) Artemisinins: their growing importance in medicine Trends Pharmacol Sci 29(10) pp 520-27 DOI: 10.1016/j. tips.2008.07.004 PMID: 18752857 PMCID: 2758403
5. Jansen FH et al (2011) First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers Anticancer Res 31(12) pp 4417-22 PMID: 22199309
6. Ericsson T et al (2014) Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer Eur J Clin Pharmacol 70(12) pp 1453-63 doi: 10.1007/s00228-014-1754-2 PMID: 25248945
7. Krishna S et al (2015) a Randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer EBioMedicine 2(1) pp 82-90 DOI: 10.1016/j.ebiom.2014.11.010 PMID: 26137537 PMCID: 4484515
8. Retsky M et al (2013) Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review Curr Med Chem 20(33) pp 4163-76 DOI: 10.2174/09298673113209990250 PMID: 23992307 PMCID: 3831877
9. Horowitz M et al (2015) Exploiting the critical perioperative period to improve long-term cancer outcomes Nat Rev Clin Oncol pp 1-14
10. Restivo A et al (2015) Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer Br J Cancer (September) pp 1-7
11. Forget P et al (2013) Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial Med Hypotheses 81(4) pp 707-12 doi: 10.1016/j.mehy.2013.07.033 PMID: 23937996
12. Pantziarka P et al (2014) Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent ecancer 8 p 485 DOI: 10.3332/ecancer.2014.485 PMID: 25525463 PMCID: 4268104
13. Pantziarka P et al (2014) The repurposing drugs in oncology (ReDO) project ecancer 8 p 442 DOI: 10.3332/ecancer.2014.485
14. Pantziarka P et al (2015) Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy? Future oncology (London, England) 11(2) pp 181-4 DOI: 10.2217/fon.14.244
15. Sukhatme VP et al (2014) Financial orphan therapies looking for adoption Health Affairs [online] available from: http://healthaffairs.org/blog/2014/03/06/financial-orphan-therapies-looking-for-adoption/ (accessed 27 March 2014)